Previous Nav
Net Change on 15-01-2021
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Dr. Reddys Laboratories Limited
Sun Pharmaceutical Industries Limited
Cipla Limited
Divi's Laboratories Limited
Lupin Limited
Aurobindo Pharma Limited
Apollo Hospitals Enterprise Limited
Torrent Pharmaceuticals Limited
Biocon Limited
Zydus Wellness Limited
IPCA Laboratories Limited
Cadila Healthcare Limited
METROPOLIS HEALTHCARE LIMITED
Fortis Healthcare Limited
Atul Limited
Alkem Laboratories Limited
Sanofi India Limited
Clearing Corporation of India Limited
Pfizer Limited
Strides Pharma Science Limited
Abbott India Limited
Indoco Remedies Limited
Eris Lifesciences Limited
Gland Pharma Limited
Ajanta Pharmaceuticals Limited
Net Receivables / (Payables)
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Consumer Food
Chemicals
Miscellaneous
Cash
Equity
Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹459.12 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.
The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended down ₹-0.21(-1.24%)yesterday to ₹16.71.
Among its top 3 holdings the fund has exposure to Dr. Reddys Laboratories Limited, and
The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .
One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013